What is the price-to-earnings ratio of Novartis?
The price-earnings ratio of Novartis is currently 3.95.
Novartis P/S 2024
Novartis P/S
3.95
Novartis Dividend yield
3.45 %
Ticker
NOVN.SW
ISIN
CH0012005267
WKN
904278
As of Apr 19, 2024, Novartis's P/S ratio stood at 3.95, a -3.66% change from the 4.1 P/S ratio recorded in the previous year.
The Novartis P/S history
Novartis Aktienanalyse
What does Novartis do?
Novartis AG is a globally active company operating in the pharmaceutical, ophthalmology, and generics manufacturing sectors. The company, headquartered in Basel, Switzerland, was founded in 1996 and originated from a merger between Ciba-Geigy and Sandoz. Novartis AG is now a leading company worldwide in the research, development, production, and marketing of pharmaceuticals and other health products. Novartis ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Novartis's P/S Ratio
Novartis's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Novartis's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Novartis's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Novartis’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Novartis Stock
How has the price-earnings ratio of Novartis changed compared to last year?
The price-to-earnings ratio of Novartis has increased by -3.66% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Novartis high compared to other companies?
Yes, the price-to-earnings ratio of Novartis is high compared to other companies.
How does an increase in the price-earnings ratio of Novartis affect the company?
An increase in the price-earnings ratio of Novartis would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Novartis affect the company?
A decrease in the price-earnings ratio of Novartis would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Novartis?
Some factors that influence the price-earnings ratio of Novartis are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Novartis pay?
Over the past 12 months, Novartis paid a dividend of 3.2 USD . This corresponds to a dividend yield of about 3.45 %. For the coming 12 months, Novartis is expected to pay a dividend of 3.28 USD.
What is the dividend yield of Novartis?
The current dividend yield of Novartis is 3.45 %.
When does Novartis pay dividends?
Novartis pays a quarterly dividend. This is distributed in the months of April, April, April, April.
How secure is the dividend of Novartis?
Novartis paid dividends every year for the past 26 years.
What is the dividend of Novartis?
For the upcoming 12 months, dividends amounting to 3.28 USD are expected. This corresponds to a dividend yield of 3.54 %.
In which sector is Novartis located?
Novartis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Novartis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Novartis from 3/11/2024 amounting to 3.3 USD, you needed to have the stock in your portfolio before the ex-date on 3/7/2024.
When did Novartis pay the last dividend?
The last dividend was paid out on 3/11/2024.
What was the dividend of Novartis in the year 2023?
In the year 2023, Novartis distributed 3.1 USD as dividends.
In which currency does Novartis pay out the dividend?
The dividends of Novartis are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Novartis stock can be added to a savings plan with the following providers: ING
Andere Kennzahlen von Novartis
Our stock analysis for Novartis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novartis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
